Walnut Consumption Controlled Trial
Walnut Consumption Alters the Gastrointestinal Microbiota, Microbially Derived Secondary Bile Acids, and Health Markers in Healthy Adults: A Randomized Controlled Trial
Walnut consumption affected the composition and function of the human gastrointestinal microbiota and reduced microbially derived, pro-inflammatory secondary bile acids and LDL cholesterol suggesting that the influence on gut microbiota might partly be responsible for the health benefits ascribed to walnuts.
Source: The Journal of Nutrition
Related stories
- Saving the PASS system for the sake of England’s FH Services, for current and future generations
- The national Child Parent Screening Service (CPSS) pilot has been extended until October 2024
- Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
- how the NHS is working to deliver improved lipid management
- HEART UK 36th Annual Medical and Scientific Conference 2023 LIPIDS – THE BEST YET - CONFERENCE REVIEW
- Our new Lipidology Podcast
- Recently formed Lipoprotein(a) Taskforce publishes Call to Action to increase recognition and acceptance of Lp(a) as an ASCVD risk factor
- Lipoprotein (a) disorder gets SNOMED codes
- Would you like to update your knowledge of lipid management and have the opportunity to liaise with others working in this area?
- Familial Hypercholesterolaemia Gene Testing One-Day Online Workshop - Dates for 2023